Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis‐Associated Genes in Acute Myeloid Leukemia
Cong Liang,
No information about this author
Zhi‐Qing Long,
No information about this author
Mengjie Lei
No information about this author
et al.
Molecular Carcinogenesis,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 27, 2025
Acute
myeloid
leukemia
(AML)
is
marked
by
the
proliferation
of
abnormal
progenitor
cells
in
bone
marrow
and
blood,
leading
to
low
cure
rates
despite
new
drug
approvals
from
2017
2018.
Current
therapies
often
fail
due
emergence
resistance
mechanisms,
such
as
those
involving
anti-apoptotic
pathways
immune
evasion,
highlighting
an
urgent
need
for
novel
approaches
overcome
these
limitations.
Programmed
cell
death
(PCD)
crucial
tissue
homeostasis,
with
PANoptosis-a
form
PCD
integrating
pyroptosis,
apoptosis,
necroptosis-recently
identified.
This
process,
regulated
PANoptosome
complex,
could
be
key
overcoming
AML
resistance.
Targeting
multiple
simultaneously
may
prove
more
effective
than
single-target
therapies.
Research
suggests
that
disrupting
Bcl-2,
can
enhance
sensitivity
AML.
study
hypothesizes
PANoptosis-associated
genes
(PARGs)
play
a
critical
role
modulating
responses
offers
multi-faceted
approach
tackle
this
challenge.
Using
RNA
sequencing
data
Cancer
Genome
Atlas
Gene
Expression
Omnibus
databases,
we
performed
differential
expression
analysis
identify
significantly
dysregulated
PARGs
Regression
identified
prognostic
PARGs,
bridging
gap
understanding
how
contribute
treatment
We
then
verified
their
lines
samples
treated
cytarabine
using
RT-qPCR.
Hierarchical
clustering
revealed
distinct
PARG
patterns,
functional
enrichment
highlighted
involvement
immune-related
pathways.
The
combination
bioinformatics
experimental
validation
underscores
mediate
modulation
resistance,
providing
robust
framework
further
study.
Our
findings
suggest
provide
potential
targets
therapeutic
intervention.
highlights
targeting
improve
outcomes
By
analyzing
changes
response
standard
clinical
treatments,
developing
multi-target
strategies
disrupt
programmed
Such
directly
addresses
limitations
current
treatments
offering
method
mitigate
potentially
improving
survival
rates.
underscore
importance
comprehensive
mechanisms
pave
way
innovative
impact
management.
Language: Английский
Glutathiones’ life in multi-cancers: especially their potential micropetides in liver hepatocellular carcinoma
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 18, 2025
Glutathione
plays
critical
roles
in
detoxifying
xenobiotics,
cell
signaling,
death
and
the
antioxidant
defence
an
emerging
body
of
evidence,
most
abundant
intracellular
low
molecular
weight
thiol
tissues.
However,
all
glutathione
metabolism
pertinent
genes
(GMPGs)
expression
their
diagnostic/prognostic/micropeptide
potential
analyses
have
not
been
investigated
to
perform
pan-cancers.
We
gained
GMPGs
from
MsigDB
7.2,
12,123
samples
were
used
reveal
differentially
expressed
(DEGs)
survival
analysis
32
types
cancers
TCGA,
GTEx,
GEO
datasets
for
first
time.
All
statistical
performed
by
R
bioinformatics,
such
as
DEGs,
prognostic,
diagnostic
analysis,
ceRNA,
micropeptide
prediction
immune
infiltration.
In
addition,
we
utilized
siRNA
technology
target
knockdown
G6PD
gene
Huh7
hepatocellular
carcinoma
cells.
was
significantly
poor
prognosis
liver
(LIHC)
predicted
RBM26-AS1
encoded
might
LIHC.
vitro
experiments
show
that
knockout
cells
reduces
proliferation,
migration,
invasion
capabilities.
confirmed
played
a
crucial
role
occurrence
progression
is
positively
associated
with
Th2
LIHC,
regulating
responses
system.
considered
be
new
player
involved
LIHC
interacting
G6PD,
key
function
cancer.
Language: Английский
CDCA8 and its multifaceted role in tumorigenesis
Biomedicine & Pharmacotherapy,
Journal Year:
2025,
Volume and Issue:
185, P. 117951 - 117951
Published: March 8, 2025
Language: Английский
Unravelling the Role of PANoptosis in Liver Diseases: Mechanisms and Therapeutic Implications
Liver International,
Journal Year:
2025,
Volume and Issue:
45(4)
Published: March 21, 2025
PANoptosis
is
a
multimodal
form
of
cell
death
that
involves
inflammatory,
apoptotic,
and
necroptotic
pathways,
playing
key
role
in
the
development
liver
diseases.
This
article
first
outlines
definition
characteristics
PANoptosis,
then
explores
its
mechanisms
action
different
types
diseases,
including
acute
injury,
failure,
metabolic
dysfunction-associated
fatty
disease,
hepatocellular
carcinoma.
Furthermore,
this
analyses
molecular
regulatory
network
potential
therapeutic
targets.
Finally,
summarises
current
research
on
diseases
future
directions,
it
reviews
emerging
mechanism
Language: Английский
The molecular mechanisms, roles, and potential applications of PANoptosis in cancer treatment
Wenyuan Ma,
No information about this author
Qiang Wang,
No information about this author
Lanfang Guo
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 29, 2025
PANoptosis,
a
newly
identified
form
of
programmed
cell
death
regulated
by
the
panoptosome
complex,
exhibits
key
characteristics
apoptosis,
pyroptosis
and
necroptosis.
It
exerts
substantial
influence
on
initiation
progression
spectrum
diseases,
particularly
in
cancer,
where
its
impact
is
increasingly
being
recognized.
PANoptosis
closely
related
to
tumorigenesis,
carcinogenesis,
metastasis,
chemotherapy
resistance,
as
well
prediction
therapeutic
responses
prognosis
cancer
patients.
In
this
review,
we
first
review
discovery
systematically
analyze
composition
panoptosome.
Subsequently,
examine
role
various
types
encompassing
function
within
tumor
microenvironment,
drug
predictive
prognosis.
Ultimately,
delve
into
strategies
for
targeting
therapy,
including
molecules
pathway,
such
ZBP1,
RIPK1,
RIPK3,
Caspases
other
novel
like
nanoinducers
viral
vectors.
This
aims
provide
references
assistance
research
application
treatment.
Language: Английский
Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024
Kun Huang,
No information about this author
Ye He,
No information about this author
Hao Wan
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 15, 2024
Background
Regulated
cell
death
(RCD)
is
a
genetically
controlled
form
of
that
plays
an
important
role
in
organogenesis,
tissue
remodeling,
and
pathogenesis
cancers.
Transforming
growth
factor-beta-activation
kinase
1
(TAK1)
member
the
serine/threonine
protein
family,
which
can
respond
to
internal
external
stimuli
participate
inflammatory
responses
through
multiple
signaling
pathways
cellular
processes.
In
last
two
decades,
regulatory
roles
TAK1
at
crossroads
RCD
pathways,
including
apoptosis,
necroptosis,
pyroptosis,
PANoptosis
were
revealed
by
801
articles
retrieved
from
Web
Science
Core
Collection
database.
To
analyze
global
research
trends
hotspots
concerning
RCD,
bibliometric
visualized
analysis
applied
current
study.
Methods
The
data
for
this
bibliometrics
study
search
formula
was
(TS=(Apoptosis)
OR
TS=(pyroptosis)
TS=(Necroptosis)
TS=(PANoptosis)
TS=(Autophagy)
TS=(Ferroptosis)
TS=(cuproptosis))
AND
((TS=(TAK1))
TS=(MAP3K7)).
co-occurrence
co-cited
on
basic
parameters
conducted
VOSviewer.
dual-map
overlay
journals,
citation
bursts,
keyword
timelines,
bursts
analyzed
CiteSpace.
Results
A
total
46
countries
have
been
included
analysis.
number
publications
demonstrates
consistent
increase
1999
2024.
primary
institutions
driving
field
are
Osaka
University
Notably,
Journal
Biological
Chemistry
stands
out
as
most
popular
journal
domain.
These
collectively
involve
contributions
4663
authors,
with
Jun
Tsuji
emerging
prolific
author.
also
gains
highest
co-citation
frequency.
Emerging
encapsulated
keywords,
NF-κB,
inflammation,
autophagy,
TNFα.
Conclusion
This
first
RCD.
Based
articles,
results
provide
retrospective
comprehensive
view
frontiers
propose
ideas
guiding
their
future
investigations
molecular
mechanisms
therapeutic
strategies
field.
Language: Английский
Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy
Guanghui Hou,
No information about this author
Youdong Chen,
No information about this author
Huali Lei
No information about this author
et al.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 19, 2024
Abstract
Malignant
tumors
pose
a
significant
threat
to
global
public
health.
Promoting
programmed
cell
death
in
cancer
cells
has
become
critical
strategy
for
treatment.
PANoptosis,
newly
discovered
form
of
regulated
death,
integrates
key
molecular
components
pyroptosis,
apoptosis,
and
necroptosis,
activating
these
three
pathways
simultaneously
achieve
synergistic
multi‐mechanistic
killing.
PANoptosis
significantly
inhibits
growth
resistance
activates
strong
anti‐tumor
immune
response,
making
tumor‐specific
induction
potential
therapeutic
strategy.
Currently,
treatment
research
related
is
focused
mainly
on
the
development
small
molecules
cytokines.
However,
approaches
still
face
limitations
terms
metabolic
stability
tumor
specificity.
The
unique
physicochemical
properties
biological
activities
nanomaterials
hold
promise
optimizing
strategies.
This
review
summarizes
concept
mechanisms
highlights
latest
applications
nanoagents
PANoptosis‐based
anti‐cancer
therapy,
discusses
challenges
future
directions
clinical
translation.
It
hoped
that
this
will
inspire
further
exploration
treatments,
providing
new
perspectives
researchers
field.
Language: Английский
Nanomaterials‐Induced PANoptosis: A Promising Anti‐Tumor Strategy
Guanghui Hou,
No information about this author
Youdong Chen,
No information about this author
Huali Lei
No information about this author
et al.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 19, 2024
Abstract
Malignant
tumors
pose
a
significant
threat
to
global
public
health.
Promoting
programmed
cell
death
in
cancer
cells
has
become
critical
strategy
for
treatment.
PANoptosis,
newly
discovered
form
of
regulated
death,
integrates
key
molecular
components
pyroptosis,
apoptosis,
and
necroptosis,
activating
these
three
pathways
simultaneously
achieve
synergistic
multi‐mechanistic
killing.
PANoptosis
significantly
inhibits
growth
resistance
activates
strong
anti‐tumor
immune
response,
making
tumor‐specific
induction
potential
therapeutic
strategy.
Currently,
treatment
research
related
is
focused
mainly
on
the
development
small
molecules
cytokines.
However,
approaches
still
face
limitations
terms
metabolic
stability
tumor
specificity.
The
unique
physicochemical
properties
biological
activities
nanomaterials
hold
promise
optimizing
strategies.
This
review
summarizes
concept
mechanisms
highlights
latest
applications
nanoagents
PANoptosis‐based
anti‐cancer
therapy,
discusses
challenges
future
directions
clinical
translation.
It
hoped
that
this
will
inspire
further
exploration
treatments,
providing
new
perspectives
researchers
field.
Language: Английский
Identification and validation of PANoptosis-based HNSCPAN-index as a prognostic model for head and neck squamous cell carcinoma
Yun Feng,
No information about this author
Qinglai Tang,
No information about this author
Xiaojun Tang
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
Abstract
PANoptosis,
a
recently
characterized
form
of
programmed
cell
death,
remains
incompletely
understood
in
the
context
Head
and
Neck
Squamous
Cell
Carcinoma
(HNSCC).
In
this
study,
we
identified
prognostically
relevant
set
PANoptosis
genes
within
The
Cancer
Genome
Atlas
(TCGA)
database
for
HNSCC
uncovered
three
molecular
subtypes
based
on
their
expression
profiles.
Each
subtype
exhibited
distinct
prognostic
outcomes
immune
infiltration
patterns.
To
further
elucidate
clinical
relevance,
constructed
risk
score
model,
termed
HNSCPAN-index,
using
least
absolute
shrinkage
selection
operator
(LASSO)
Cox
regression
differentially
expressed
across
subtypes.
Patients
were
stratified
into
high-risk
low-risk
groups
according
to
HNSCPAN-index.
predictive
power
model
was
evaluated
Kaplan-Meier
analysis,
ROC,
nomogram
validated
an
external
dataset.
A
lower
HNSCPAN-index
correlated
with
longer
overall
survival
enhanced
immunotherapy
responses,
whereas
higher
indicated
increased
sensitivity
small-molecule
targeted
therapies.
Moreover,
demonstrated
strong
correlation
chemotherapeutic
drug
sensitivity.
Finally,
DSCAM
as
key
regulator
HNSCC,
where
silencing
death
mediated
by
pyroptosis
inducers.
conclusion,
revealed
its
potential
role
prognosis,
TME,
chemotherapy.
These
findings
may
provide
deeper
understanding
pave
way
development
more
personalized
therapeutic
strategies.
Language: Английский
Mitochondrial Gene Scoring System: Predicting Prognosis and Precision Therapy for TACE Non-Response in Hepatocellular Carcinoma Patients
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
16(2), P. 629 - 647
Published: Dec. 31, 2024
Given
the
crucial
role
of
mitochondria
in
prognosis
and
treatment
hepatocellular
carcinoma
(HCC),
we
aim
to
develop
two
independent
mitochondrial
scoring
systems
separately
predict
patient
likelihood
transarterial
chemoembolization
non-response
(TACE
NR).
Language: Английский